The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy |
| |
| Authors: | Ruth Scherz-Shouval,Sandro Santagata,Marc L. Mendillo,Lynette M. Sholl,Irit Ben-Aharon,Andrew H. Beck,Dora Dias-Santagata,Martina Koeva,Salomon M. Stemmer,Luke Whitesell,Susan Lindquist |
| |
| Affiliation: | 1 Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA;2 Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02215, USA;3 Department of Cancer Biology, Dana Farber Cancer Center, Boston, MA 02215, USA;4 Institute of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva 49100, Israel;5 Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv 69978, Israel;6 Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA;7 Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA;8 Harvard Medical School, Boston, MA 02215, USA;9 Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA;10 Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA;11 Howard Hughes Medical Institute, Cambridge, MA 02142, USA |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
